Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Sandoz Group Ag (0SAN) Share Price

Price 49.72348 on 28-10-2025 at 16:35:32
Change 0.00 0%
Buy 0.00
Sell 0.00
Last Trade: Unknown 3,288.00 at 49.72348
Day's Volume: 24,276
Last Close: 49.72348
Open: 0.00
ISIN: CH1243598427
Day's Range 0.00 - 0.00
52wk Range: 30.61 - 50.42964
Market Capitalisation: -
VWAP: 49.75694
Shares in Issue: 430.70m

Sandoz Group Ag (0SAN) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Unknown* 3,288 49.72348 SI Trade
Negotiated Trade
16:33:03 - 28-Oct-25
Unknown* 16 49.72 SI Trade
16:31:40 - 28-Oct-25
Unknown* 2,091 49.72 SI Trade
16:31:40 - 28-Oct-25
Unknown* 157 49.72 SI Trade
16:31:40 - 28-Oct-25
Unknown* 573 49.60 OTC Trade
16:17:17 - 28-Oct-25
Unknown* 573 49.60 SI Trade
16:17:17 - 28-Oct-25
Unknown* 49 49.62 OTC Trade
16:06:23 - 28-Oct-25
Unknown* 49 49.62 SI Trade
16:06:23 - 28-Oct-25
Unknown* 153 49.62 OTC Trade
16:06:15 - 28-Oct-25
Unknown* 153 49.62 SI Trade
16:06:15 - 28-Oct-25
See more Sandoz Group Ag trades

Sandoz Group Ag (0SAN) Share Price History

Time period:
to
Date Open High Low Close Volume
28th Oct 2025 (Tue) 49.72348 49.72348 49.72348 49.72348 24,276
27th Oct 2025 (Mon) 49.79 49.79 49.79 49.79 21,382
24th Oct 2025 (Fri) 49.55 49.55 49.55 49.55 61,532
23rd Oct 2025 (Thu) 48.5913 48.5913 48.5913 48.5913 91,122
22nd Oct 2025 (Wed) 48.5612 48.5612 48.5612 48.5612 44,419
21st Oct 2025 (Tue) 48.64333 48.64333 48.64333 48.64333 34,820
20th Oct 2025 (Mon) 48.9262 48.9262 48.9262 48.9262 61,921
17th Oct 2025 (Fri) 48.18879 48.18879 48.18879 48.18879 25,552
16th Oct 2025 (Thu) 48.37722 48.37722 48.37722 48.37722 146,255
15th Oct 2025 (Wed) 48.80412 48.80412 48.80412 48.80412 682,536
14th Oct 2025 (Tue) 48.71722 48.71722 48.71722 48.71722 149,403
13th Oct 2025 (Mon) 48.86449 48.86449 48.86449 48.86449 155,272
10th Oct 2025 (Fri) 49.36 49.36 49.36 49.36 472,659
9th Oct 2025 (Thu) 49.13862 49.13862 49.13862 49.13862 50,021
8th Oct 2025 (Wed) 48.18693 48.18693 48.18693 48.18693 219,125
7th Oct 2025 (Tue) 47.77408 47.77408 47.77408 47.77408 194,000
6th Oct 2025 (Mon) 47.63516 47.63516 47.63516 47.63516 252,503
3rd Oct 2025 (Fri) 46.3304 46.3304 46.3304 46.3304 45,499
2nd Oct 2025 (Thu) 45.2919 45.2919 45.2919 45.2919 277,457
1st Oct 2025 (Wed) 46.2931 46.2931 46.2931 46.2931 322,409
30th Sep 2025 (Tue) 47.0768 47.0768 47.0768 47.0768 136,278
29th Sep 2025 (Mon) 47.42 47.42 47.42 47.42 44,557
See more Sandoz Group Ag price history

Sandoz Group Ag (0SAN) Regulatory News

Date Source Headline
12th Aug 2025 6:00 am GNW Sandoz launches renewable energy partnership to cover nearly 90% of electricity demand for European operations
7th Aug 2025 6:00 am GNW Sandoz delivers strong H1 2025 results, with accelerated sales growth in the second quarter
30th Jul 2025 6:15 am GNW Sandoz signs non-binding term sheet with Evotec SE to acquire its Just-Evotec Biologics in-house development and manufacturing capabilities in Toulouse, France
1st Jul 2025 1:56 pm GNW Sandoz further asserts leadership in biosimilars, breaking ground on new Slovenia facility to expand European biosimilar hub and global market reach
2nd Jun 2025 6:00 am GNW Sandoz launches first and only interchangeable denosumab biosimilars in US, providing new affordable treatment options for over 10 million patients[1]
21st May 2025 4:30 pm GNW Sandoz launches Pyzchiva® autoinjector, first commercially available in Europe for ustekinumab biosimilars
30th Apr 2025 6:00 am GNW Sandoz reports Q1 2025 net sales in line with company expectations; full-year guidance confirmed
29th Apr 2025 4:00 pm GNW Sandoz enters global collaboration license agreement with Henlius to commercialize leading oncology therapy, ipilimumab, in multiple indications
15th Apr 2025 12:50 pm GNW Shareholders approve all resolutions proposed by Board of Directors at Annual General Meeting of Sandoz Group AG
14th Apr 2025 3:00 pm GNW [Corrected] Sandoz files antitrust litigation against Amgen regarding patient access to etanercept biosimilar in the US
See more Sandoz Group Ag regulatory news
FTSE 100 Latest
Value9,696.74
Change42.92

Login to your account

Forgot Password?

Not Registered